Details of Host Protein
Host Protein General Information (ID: PT0003) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
14-3-3 protein epsilon (14-3-3E)
|
Gene Name |
YWHAE
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
1433E_HUMAN
|
||||||
Protein Families |
14-3-3 family
|
||||||||
Subcellular Location |
Nucleus Cytoplasm Melanosome
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Adapter protein implicated in the regulation of a largespectrum of both general and specialized signaling pathways. Binds to alarge number of partners, usually by recognition of a phosphoserine orphosphothreonine motif. Binding generally results in the modulation ofthe activity of the binding partner. Positivelyregulates phosphorylated protein HSF1 nuclear export to the cytoplasm.
[1]
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
NOD-like receptor signaling pathway | hsa04621 |
Pathway Map ![]() |
|||||||
Hepatitis C | hsa05160 |
Pathway Map ![]() |
|||||||
Viral carcinogenesis | hsa05203 |
Pathway Map ![]() |
|||||||
Cell cycle | hsa04110 |
Pathway Map ![]() |
|||||||
Oocyte meiosis | hsa04114 |
Pathway Map ![]() |
|||||||
PI3K-Akt signaling pathway | hsa04151 |
Pathway Map ![]() |
|||||||
Hippo signaling pathway | hsa04390 |
Pathway Map ![]() |
|||||||
Neurotrophin signaling pathway | hsa04722 |
Pathway Map ![]() |
|||||||
3D Structure |
|
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: ORF10 (hCoV-19/Not Specified Virus Strain ) | |||||||||
RNA Region Details |
RNA Info
![]() |
[2] | |||||||
Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
RNA Binding Region |
ORF10
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Calu-3 cells (Human Lung Cancer Cell) (CVCL_0609 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Interaction Score | P-value < 0.05 | ||||||||
Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) |